Literature DB >> 26237887

[Update on Current Care Guideline: Diabetic retinopathy].

Paula Summanen, Vuokko Kallioniemi, Jorma Komulainen, Lars Eriksson, Heikki Forsvik, Kustaa Hietala, Sirkku Tulokas, Gunvor Von Wendt.   

Abstract

Good treatment of diabetes decreases the risk of diabetic retinopathy. The goals of the treatment are adequate glucose balance, blood pressure and prevention of metabolic syndrome. Every patient with diabetes should regularly be screened for diabetic retinopathy. Timely and efficient treatment of retinopathy significantly decreases the risk of visual impairment.

Entities:  

Mesh:

Year:  2015        PMID: 26237887

Source DB:  PubMed          Journal:  Duodecim        ISSN: 0012-7183


  3 in total

1.  Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study.

Authors:  Joonas Wirkkala; Anna-Maria Kubin; Pasi Ohtonen; Joona Yliselä; Taru Siik; Nina Hautala
Journal:  BMC Ophthalmol       Date:  2022-06-09       Impact factor: 2.086

2.  Deep Learning Fundus Image Analysis for Diabetic Retinopathy and Macular Edema Grading.

Authors:  Jaakko Sahlsten; Joel Jaskari; Jyri Kivinen; Lauri Turunen; Esa Jaanio; Kustaa Hietala; Kimmo Kaski
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

3.  Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy.

Authors:  Joonas Wirkkala; Risto Bloigu; Nina Maria Hautala
Journal:  BMJ Open Ophthalmol       Date:  2019-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.